Bharat Biotech, Serum Institute of India Developing Intranasal Vaccines for COVID-19; What Is an Intranasal Vaccine? Updates on Anti-Coronavirus Intranasal Vaccines슬롯사이트� Development
Union Health Minister Dr Harsh Vardhan on Sunday informed that Bharat Biotech and Serum Institute of India (SII) are developing intranasal vaccines for Sars-CoV-2.
New Delhi, October 19: Bharat Biotech and슬롯 머신 사이트 추천Serum Institute of India (SII) are developing intranasal vaccines for Sars-CoV-2, the virus that causes coronavirus or COVID-19, Union Health Minister Dr Harsh Vardhan said on Sunday. Dr Harsh Vardhan informed that Bharat Biotech슬롯 머신 사이트 추천has entered into an agreement with Washington University and St. Louis University for the trials of the nasal vaccine candidate.슬롯 머신 사이트 추천COVID-19 Vaccine Update: UK's Most Vulnerable Could Get Coronavirus Vaccine 'by Christmas 2020'.
"It (Bharat Biotech) has entered into an agreement with Washington University's School of Medicine under which the company will conduct trials, produce and market an intranasal vaccine for the COVID-19,"슬롯 머신 사이트 추천the Health Minister said. He added that슬롯 머신 사이트 추천the Serum Institute of India is working with슬롯 머신 사이트 추천the US-based biotech company Codagenix for the슬롯 머신 사이트 추천development of another intranasal vaccine called슬롯 머신 사이트 추천CDX-005.
"Codagenix is collaborating with the Serum Institute of India to develop CDX-005, which is the company's intranasal, live-attenuated vaccine candidate for SARS-CoV-2," Vardhan said.슬롯 머신 사이트 추천When Will India Get COVID-19 Vaccine? Here's Where AstraZeneca, Sputnik V And Other Vaccine Trials Stand in India.
What is an Intranasal Vaccine?
Vaccines are delivered through different routes. For example, some vaccines are administered by injection. Similarly, for infants, vaccines are delivered orally. An intranasal vaccine is슬롯 머신 사이트 추천administered슬롯 머신 사이트 추천by squirting or spraying the solution into the nostrils. The use of intranasal vaccines reduces the need for syringes, needles and alcohol-based swabs.
Update on Bharat Biotech's Intranasal Vaccine Candidate For COVID-19:
The phase 1 trial of an intranasal vaccine against coronavirus infection, developed by Bharat Biotech,슬롯 머신 사이트 추천will take place in St Louis University's vaccine and treatment evaluation unit. Upon receiving regulatory approval,슬롯 머신 사이트 추천Bharat Biotech will also conduct슬롯 머신 사이트 추천further stages of clinical trials in India. Dr Harsh Vardhan said슬롯 머신 사이트 추천late-stage trial generally involves thousands of participants.
Update on슬롯 머신 사이트 추천Intranasal Vaccine Candidate For COVID-19 Developed by슬롯 머신 사이트 추천Serum Institute of India:
The슬롯 머신 사이트 추천CDX-005, an intranasal vaccine developed by슬롯 머신 사이트 추천Codagenix along with Serum Institute of India, will undergo phase 1 first-in-human clinical trial in the United Kingdom by the end of 2020. Pre-clinical animal studies have been successfully completed.슬롯 머신 사이트 추천CDX-005 is a single dose intranasal vaccine made with a live attenuated version of the virus, unlike most vaccine candidates that are made by using슬롯 머신 사이트 추천a dead virus, genetic material from the virus, or components of the virus, such as the spike protein.
(The above story first appeared on LatestLY on Oct 19, 2020 10:48 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).